The global Brachytherapy Market was valued at USD 949.86 million in 2023, projected to reach USD 1,775.84 million by 2032, growing at a CAGR of 7.23%. The U.S. market is forecasted to hit USD 504.89 million by 2032 at a CAGR of 5.54%. This growth is driven by the rising prevalence of cancer and advanced imaging techniques enhancing precision in tumor targeting.
Brachytherapy, or internal radiation therapy, places radioactive sources inside or near the tumor site for cancers like prostate, cervical, breast, and skin. It offers shorter treatment times and better patient compliance compared to external beam radiation. Leading cancer centers in the U.S. are increasingly investing in brachytherapy systems supported by favorable reimbursement policies.
In 2023, High-Dose Rate (HDR) brachytherapy held the maximum market share due to its efficiency and outpatient availability. LDR Brachytherapy is the fastest-growing segment due to its long-term effectiveness in prostate cancer treatment. Applicators & Afterloaders held the largest share in 2023, followed by implantation devices, with brachytherapy seeds being the fastest-expanding product category.
Prostate cancer remains the leading application segment in 2023, with gynecological cancer emerging as the fastest-growing application due to increasing awareness and early diagnosis. North America accounted for 46.60% of the market in 2023, with the Asia-Pacific region expected to show significant growth due to increasing prevalence of cancer and improving healthcare infrastructure.
Recent developments include Varian teaming up with Sun Nuclear for quality management in brachytherapy treatments and Elekta launching a new AI-assisted treatment planning module to enhance accuracy and reduce planning time. The integration of AI-driven treatment planning and robotic-assisted delivery systems is redefining precision oncology and expanding the scope of brachytherapy applications. SNS Insider offers a comprehensive Brachytherapy Market Report with unique USP sections beyond standard market sizing and trends. The report includes therapy adoption mapping by cancer type and stage, treatment workflow analysis, cost-benefit comparisons, regulatory intelligence, innovation heatmap, sentiment insights, and competitor supply chain matrix. Access the detailed report for in-depth analysis and outlook. Contact [email protected] for customization or more information.
Read more at GlobeNewswire: Brachytherapy Market Size to Reach USD 1.78 Billion by